Skip to content

Comparison of Two Multifocal Contact Lenses Worn on a Daily Disposable Basis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01254760
Enrollment
79
Registered
2010-12-07
Start date
2010-12-31
Completion date
2011-01-31
Last updated
2012-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia, Presbyopia

Brief summary

The purpose of this trial is to evaluate and compare the clinical performance of two multifocal contact lenses.

Interventions

DEVICENelfilcon A multifocal contact lens, investigational

Investigational, soft, multifocal contact lens for daily wear, daily disposable use.

DEVICENelfilcon A multifocal contact lens, commercial

Commercially marketed, soft, multifocal contact lens FDA-approved for daily wear, daily disposable use.

Sponsors

CIBA VISION
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
41 Years to 68 Years
Healthy volunteers
No

Inclusion criteria

* Age 41 to 68 (inclusive). * Spectacle add between +0.75 and +2.75D (inclusive). * Habitual spectacle prescription ≤ 1.00DC (cyl). * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* Eye injury or surgery within twelve weeks of enrollment. * Pre-existing ocular irritation that would preclude contact lens fitting. * Currently enrolled in a clinical trial. * Prior refractive surgery. * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
End of Day Comfort5 days of wear, lenses replaced dailyEnd of day comfort was interpreted and reported by the participant on a questionnaire as a single, retrospective evaluation of 5 days of wear. End of day comfort was measured on a 10-point scale, with 1 being poor and 10 being excellent.
End of Day Dryness5 days of wear, lenses replaced dailyEnd of day dryness was interpreted and reported by the participant on a questionnaire as a single, retrospective evaluation of 5 days of wear. End of day dryness was measured on a 10-point scale, with 1 being very dry and 10 being not dry.
Handling at Removal5 days of wear, lenses replaced dailyHandling at removal was interpreted and reported by the participant on a questionnaire as a single, retrospective evaluation of 5 days of wear. Handling at removal was measured on a 10-point scale, with 1 being poor/difficult and 10 being excellent/easy.
Overall Vision5 days of wear, lenses replaced dailyOverall vision was interpreted and reported by the participant on a questionnaire as a single, retrospective evaluation of 5 days of wear. Overall vision was measured on a 10-point scale, with 1 being poor and 10 being excellent.

Secondary

MeasureTime frameDescription
Overall FitDay 5, lenses replaced dailyOverall lens fit was assessed by the investigator at study visit using a biomicroscope, which magnifies the appearance of the contact lens on the participant's eye. Lens fit was assessed by eye and graded on a 5-point scale, with 2=unacceptably loose, 1= acceptably loose, 0=optimal, -1=acceptably tight, and -2=unacceptably tight

Participant flow

Recruitment details

A total of 79 participants were recruited at 7 US sites from December 3, 2010, to January 20, 2011.

Pre-assignment details

Seven participants were enrolled in the study but not dispensed due to failed inclusion/exclusion criteria (2); unsatisfactory vision (2); unacceptable comfort (1); and subject withdrawal (2). These participants are included in the Actual Enrollment calculation, but not Participant Flow or Baseline Characteristics calculations.

Participants by arm

ArmCount
Overall
This reporting group includes all enrolled and dispensed participants.
72
Total72

Baseline characteristics

CharacteristicOverall
Age Continuous50.1 years
STANDARD_DEVIATION 5.7
Sex: Female, Male
Female
53 Participants
Sex: Female, Male
Male
19 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 770 / 77
serious
Total, serious adverse events
0 / 770 / 77

Outcome results

Primary

End of Day Comfort

End of day comfort was interpreted and reported by the participant on a questionnaire as a single, retrospective evaluation of 5 days of wear. End of day comfort was measured on a 10-point scale, with 1 being poor and 10 being excellent.

Time frame: 5 days of wear, lenses replaced daily

Population: Analysis conducted per protocol, with exclusions due to reasons such as: major protocol deviations as determined by masked review; discontinuations; and/or missing responses.

ArmMeasureValue (MEAN)Dispersion
Nelfilcon A InvestigationalEnd of Day Comfort7.7 Units on a scaleStandard Deviation 2.2
Nelfilcon A CommercialEnd of Day Comfort7.2 Units on a scaleStandard Deviation 2.3
Primary

End of Day Dryness

End of day dryness was interpreted and reported by the participant on a questionnaire as a single, retrospective evaluation of 5 days of wear. End of day dryness was measured on a 10-point scale, with 1 being very dry and 10 being not dry.

Time frame: 5 days of wear, lenses replaced daily

Population: Analysis conducted per protocol, with exclusions due to reasons such as: major protocol deviations as determined by masked review; discontinuations; and/or missing responses.

ArmMeasureValue (MEAN)Dispersion
Nelfilcon A InvestigationalEnd of Day Dryness7.2 Units on a ScaleStandard Deviation 2.5
Nelfilcon A CommercialEnd of Day Dryness6.9 Units on a ScaleStandard Deviation 2.5
Primary

Handling at Removal

Handling at removal was interpreted and reported by the participant on a questionnaire as a single, retrospective evaluation of 5 days of wear. Handling at removal was measured on a 10-point scale, with 1 being poor/difficult and 10 being excellent/easy.

Time frame: 5 days of wear, lenses replaced daily

Population: Analysis conducted per protocol, with exclusions due to reasons such as: major protocol deviations as determined by masked review; discontinuations; and/or missing responses.

ArmMeasureValue (MEAN)Dispersion
Nelfilcon A InvestigationalHandling at Removal8.7 Units on a ScaleStandard Deviation 1.6
Nelfilcon A CommercialHandling at Removal8.2 Units on a ScaleStandard Deviation 2.1
Primary

Overall Vision

Overall vision was interpreted and reported by the participant on a questionnaire as a single, retrospective evaluation of 5 days of wear. Overall vision was measured on a 10-point scale, with 1 being poor and 10 being excellent.

Time frame: 5 days of wear, lenses replaced daily

Population: Analysis conducted per protocol, with exclusions due to reasons such as: major protocol deviations as determined by masked review; discontinuations; and/or missing responses.

ArmMeasureValue (MEAN)Dispersion
Nelfilcon A InvestigationalOverall Vision7.2 Units on a ScaleStandard Deviation 1.9
Nelfilcon A CommercialOverall Vision6.2 Units on a ScaleStandard Deviation 2.1
Secondary

Overall Fit

Overall lens fit was assessed by the investigator at study visit using a biomicroscope, which magnifies the appearance of the contact lens on the participant's eye. Lens fit was assessed by eye and graded on a 5-point scale, with 2=unacceptably loose, 1= acceptably loose, 0=optimal, -1=acceptably tight, and -2=unacceptably tight

Time frame: Day 5, lenses replaced daily

Population: Analysis conducted per protocol, with exclusions due to reasons such as: major protocol deviations as determined by masked review; discontinuations; and/or missing responses.

ArmMeasureValue (MEAN)Dispersion
Nelfilcon A InvestigationalOverall Fit0.0 Units on a ScaleStandard Deviation 0.5
Nelfilcon A CommercialOverall Fit-0.1 Units on a ScaleStandard Deviation 0.6

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026